Digital Therapeutics Alliance speaker interview released for Disruptive Technologies in Pharma 2020 Read more
Akcea and Pfizer Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-LRx Read more
Exclusive interview with Optceutics Ltd speaker released for Ophthalmic Drugs Conference 2019 Read more
Fasenra approved in the US for self-administration in a new pre-filled auto-injector, the Fasenra Pen Read more
Goldfinch Bio Announces Licensing Agreement with Takeda for CB1 Monoclonal Antibody for the Treatment of Rare and Metabolic Kidney Diseases Read more
Prometheus Biosciences Enters Into Multi-Target Strategic Collaboration with Takeda to Develop Targeted Therapies for Inflammatory Bowel Disease Read more